Cannell & Spears’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
VCM
VPM
Cannell & Spears's LH Position: Q1 2026 in Review
Cannell & Spears reduced its Labcorp (LH) stake by 4.4% in Q1 2026, selling an estimated $1.9M and leaving 151,537 shares worth $40.4M. The position accounts for 0.79% of the portfolio, ranked #38.
Cannell & Spears first reported a position in LH in Q2 2020 and has held it in 23 quarters since. The position peaked at $74.9M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Cannell & Spears held 151,537 shares of Labcorp worth $40.4M as of Q1 2026.
- Cannell & Spears sold 7,025 Labcorp shares in Q1 2026, an estimated $1.9M.
- Labcorp made up 0.79% of Cannell & Spears's portfolio in Q1 2026, its #38 holding.
- Cannell & Spears first reported a position in Labcorp in Q2 2020 and has held it in 23 quarters since.
- Cannell & Spears's Labcorp position peaked at $74.9M in Q1 2024.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.